CDXC Niagen Bioscience, Inc.: institutional ownership and insider trading
Over the last 12 months insiders bought $45.6K and sold $0 on the open market.
Recent CDXC insider trades
- Nov 14, 2025: Pamir Ozan bought 6,685 shares ($45.6K)
- Mar 7, 2025: Lopez Carlos Luis bought 273 shares ($2.15K)
- Dec 13, 2024: Jaksch Frank L Jr sold 37,161 shares ($230K)
- Nov 22, 2024: Pamir Ozan bought 2,907 shares ($21.4K)
5%+ owners
- BlackRock, Inc.: 5.2% (Schedule 13G, filed Jul 29, 2026)